What is ADPT's P/E ratio?

ADAPTIVE BIOTECHNOLOGIES CORP (ADPT) currently trades at a P/E ratio of 280.32.

ADAPTIVE BIOTECHNOLOGIES CORP reports a Return on Equity (ROE) of -22.96%.

What is ADPT's dividend yield?

ADAPTIVE BIOTECHNOLOGIES CORP offers a dividend yield of 0.00%.

What is ADPT's Deepscope Quality Score?

Deepscope rates ADPT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ADPT?

Deepscope's AI Timing Score for ADPT is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ADPT belong to?

ADAPTIVE BIOTECHNOLOGIES CORP is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.

ADPT (NASDAQ) Stock Analysis | ADAPTIVE BIOTECHNOLOGIES CORP

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

ADPT

ADAPTIVE BIOTECHNOLOGIES CORP

US:NASDAQ STOCK Healthcare >> Diagnostics & Research News 92

USD 16.90

-1.18 (-6.53%) Day Change

Watchlist Portfolio Compare Chart

280.32

P/E

0.07

D/E

-23.0%

ROE

-9.8%

ROA

0.00%

Div Yield

-10.10

PEG

ADAPTIVE BIOTECHNOLOGIES CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 16.90 Price -1.18 (-6.53%) Day Change	NEWS SCORE: 92

ADPT, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	92
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	16.90
PBV / Sector	11.93 / -23.44
Earning Per Share	-0.31

PE / Sector	280.32 / 37.86
PEG or PE/Growth / Sector	-10.10 / 1.41
Average 1M Daily Value	25.39 M GREAT
Average 1W Daily Value	39.85 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-16.82 / 12.69
NPM Average (%) / Sector	-73.55 / 7.99
NPM Change Average (%) / Sector	-26.95 / -5.21
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-9.82 / 11.23
ROA Average (%) / Sector	-21.69 / -82.28
ROA Change Average (%) / Sector	-10.89 / 159.98
ROE (%) / Sector	-22.96 / -86.57
ROE Average (%) / Sector	-49.00 / -2.21
ROE Change Average (%) / Sector	-0.98 / -44.18
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.26
Dividend Average (%) / Sector	N/A / 1.20
Dividend Change Average (%) / Sector	N/A / 7.47

Registration Details

Analyze Date	2026-06-06 09:08:25
Symbol	ADPT
Name	ADAPTIVE BIOTECHNOLOGIES CORP
Sector	Healthcare >> Diagnostics & Research
Market	NASDAQ
Listed Shares	160.04 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	2,675.94 / 32,142.66

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1165 Eastlake Avenue East, Seattle, WA, United States, 98109

Phone: 206 659 0067

Website: https://www.adaptivebiotech.com

Employees: 624

Sector: Healthcare >> Diagnostics & Research

Description: Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.